the use of genomic markers and prostate biopsy decisions
Published 5 years ago • 195 plays • Length 33:52Download video MP4
Download video MP3
Similar videos
-
14:50
the "who's" of genomic markers: who to re biopsy
-
17:33
the "who's" of genomic markers: who to biopsy
-
12:30
the pros and cons of genomic markers for biopsy guidance
-
12:53
the "who's" of genomic markers: who to treat
-
11:03
biomarkers for prostate cancer: whom to treat
-
16:25
forward progress in molecular markers in prostate cancer
-
12:05
genomic markers and dna sequencing testing
-
10:13
the role of genetic testing in prostate cancer
-
13:24
genetics and genomic biomarkers: how molecular markers and mpmri play a role
-
2:27
ask the expert: how can genomic markers be used best to stratify which patients to treat?
-
2:38
the future of genomic markers and dna sequencing in prostate cancer youtube
-
11:54
screening and prevention of prostate cancer 2021 - who needs a biopsy?
-
9:18
screening for prostate cancer: psa: why 1.5 is the new 4
-
24:54
panel discussion - next generation genomics and prostate cancer biomarkers
-
9:27
role of mr-targeted prostate biopsy in active surveillance
-
11:39
urologic debate part 2: mri vs. molecular markers: which one should i use? markers perspective
-
9:01
implementation of prostate cancer markers in clinical practice
-
13:08
prostate biopsy and imaging controversies
-
1:23
genomic testing impacts treatment decisions in prostate cancer